AveXis competitors

AveXis Competitors include Viacord, Idera Pharmaceuticals, Akebia Therapeutics and Oxford Genetics.
Add company...
AveXis
AveXis
AveXis is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.
Viacord
Viacord
ViaCord is a biotechnology company dedicated to enabling the widespread application of human cells as medicine.
Idera Pharmaceuticals
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Akebia Therapeutics
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Oxford Genetics
Oxford Genetics
Oxford Genetics is a synthetic biology company, specializes in DNA design, protein expression optimization, and cell line development technologies and services.
Founding Date
Founding Date
2010
Founding Date
1993
Founding Date
1989
Founding Date
2007
Founding Date
2011
Type
Type
Subsidiary
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Bannockburn, US HQ
Locations
Waltham, US HQ
Locations
Cambridge, US HQ
Exton, US
Locations
Cambridge, US HQ
Locations
Oxford, GB HQ
Employees
Employees
N/A
Employees
90
Employees
62
Employees
90
Employees
54
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2.3 m
Valuation ($)
758.6 m
Valuation ($)
N/A
Twitter followers
Twitter followers
505
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
490
Twitter followers
665

Financial

Net income
Net income
($218.1m) (FY, 2017)
Net income
N/A
Net income
($66m) (FY, 2017)
Net income
($76.9m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 75m
Total funding raised
N/A
Total funding raised
$ 13.8m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Viacord
HQ
Waltham, US
Employees
90

ViaCord is a biotechnology company dedicated to enabling the widespread application of human cells as medicine.

View company
Idera Pharmaceuticals
HQ
Cambridge, US
Employees
62

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

View company
Akebia Therapeutics
HQ
Cambridge, US
Employees
90

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

View company
Oxford Genetics
HQ
Oxford, GB
Employees
54

Oxford Genetics is a synthetic biology company, specializes in DNA design, protein expression optimization, and cell line development technologies and services.

View company